Canadian Solar delivered Q2 2026 revenue of about $1.2B with a 13.9% gross margin, and storage shipments of 3.7 GWh surpassed guidance. The company opened Phase I of its U.S. HJT cell factory in Indiana and outlined a Phase II expansion to 6.3 GWp by mid-2027, reinforcing its NA manufacturing leadership. With a large 21.7 GWp solar and 84 GWh storage pipeline and a $3.5B e-STORAGE backlog, CSIQ projects meaningful earnings visibility, though near-term profitability faces ramp costs and elevated debt.
CS PowerTech, a CSIQ subsidiary, announced the Jeffersonville, Indiana HJT PV cell plant opening, reinforcing U.S. manufacturing and energy ambitions. The facility aims for >6 GWp annual capacity, supports 1,200+ jobs, and represents nearly $1 billion in local investment, with phase two expansion targeted by year-end. This strengthens CSIQ's domestic supply chain and HJT leadership over the coming years.
Canadian Solar is set to launch commercial production at a new solar-cell facility in Indiana within two months, marking a significant shift to North American manufacturing. This strategic move, driven by higher gross margins and focusing on profitable markets, could enhance investor confidence in the company's growth prospects amidst a challenging market environment.
JinkoSolar has sold a majority stake of its U.S. plant to remain eligible for crucial government subsidies. This strategic move follows new restrictions on Chinese-owned solar products, potentially benefiting JinkoSolar and revitalizing investor confidence in the sector amidst rising oil prices and geopolitical tensions.
Canadian Solar Inc.'s Q4 revenue and earnings missed expectations, leading to a significant stock drop. The revised first-quarter revenue forecast indicates continued weakness, which could pressure shares in the short term.
House passed a tax bill cutting clean energy subsidies. The removal of subsidies threatens the U.S. solar market. Shares of U.S. solar companies dropped significantly. Industry support and stability are now at risk. ENPH and peers may face dire financial consequences.
